. 2021 Oct 27;13(10):1245–1257. doi: 10.4240/wjgs.v13.i10.1245

Table 3.

Univariate analyses

Clinicopathological data					Surgical data
	Category	n	MST (m)	P value		Category	n	MST (m)	P value
Age (yr)	≥ 60	18	17.9	0.9267	Anatomical hepatectomy	-	3	39.0	0.2162
Age (yr)	< 60	12	29.7	0.9267	Anatomical hepatectomy	+	27	16.9	0.2162
Sex	Male	28	17.9	0.1584	Operation time (min)	< 340	15	28.4	0.4177
Sex	Female	2	-	0.1584	Operation time (min)	≥ 340	15	14.8	0.4177
HBV/HCV	-	6	15.0	0.2674	Blood loss (mL)	< 690	15	29.7	0.6355
HBV/HCV	+	24	29.7	0.2674	Blood loss (mL)	≥ 690	15	16.4	0.6355
Alb (g/dL)	≥ 3.7	15	33.5	0.3444	Number of tumors in the remnant liver	1-3	12	56.5	0.0283^a
Alb (g/dL)	< 3.7	15	17.4	0.3444	Number of tumors in the remnant liver	≥ 4	18	14.8	0.0283^a
T-Bil (mg/dL)	≤ 0.8	19	28.4	0.5131	POCR	+	8	56.6	0.0041^a
T-Bil (mg/dL)	> 0.8	11	16.5	0.5131	POCR	-	22	14.8	0.0041^a
PT (%)	≥ 90	17	17.9	0.7839
PT (%)	< 90	13	28.4	0.7839
ICGR15 (%)	≥ 15	12	29.7	0.6790
ICGR15 (%)	< 15	18	16.5	0.6790
AFP (ng/mL)	< 200	16	29.7	0.5569
AFP (ng/mL)	≥ 200	14	17.9	0.5569
PIVKA-II (AU/mL)	< 100	3	73.2	0.0584
PIVKA-II (AU/mL)	≥ 100	27	16.9	0.0584
Child-pugh class	A	27	29.7	< 0.0001
Child-pugh class	B	3	6.4	< 0.0001
Tumor size (cm)	≥ 10 cm	15	12.2	0.0485
Tumor size (cm)	< 10 cm	15	29.7	0.0485
Differentiation	wel/mod	17	17.9	0.5449
Differentiation	por	13	28.4	0.5449
pN	-	28	17.9	0.2335
pN	+	2	56.5	0.2335
Macrovascular invasion	-	5	9.5	0.0053
Macrovascular invasion	+	25	30.0	0.0053
BCLC stage	B	12	33.8	0.7652
BCLC stage	C	18	16.9	0.7652
Distant metastasis	-	27	28.4	0.6013
Distant metastasis	+	3	12.1	0.6013

P < 0.05. MST: Mean survival time; PT: Prothrombin time; ICGR15: Indocyanine green retention rate at 15 min; AFP: Alpha-fetoprotein; PIVKA-II: Protein induced by vitamin K absence/antagonist-II; BCLC: Barcelona Clinic Liver Cancer.